Aravinth Annamalai

Mechanistic Insights into Breast Cancer Targeting by 2-Oxo-2H-Chromene-7-yl 3-Methylbutanoate: An Integrated Computational Study

This in silico study suggests that CMBA warrants further investigation as a potential lead compound for breast cancer–related drug discovery, however, further experimental validation through in vitro and in vivo studies is required to confirm its predicted biological activity and therapeutic relevance.